WOLVERINE TRADING, LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$885,020
-68.6%
54,800
-21.7%
0.00%
-66.7%
Q2 2023$2,821,388
+148943.2%
70,027
+115.5%
0.00%0.0%
Q1 2023$1,893
-71.4%
32,500
-63.9%
0.00%
-72.7%
Q4 2022$6,611
-99.9%
90,135
+30.7%
0.01%
+37.5%
Q3 2022$5,315,000
+16.8%
68,980
+9.8%
0.01%0.0%
Q2 2022$4,549,000
-17.6%
62,832
-4.4%
0.01%
+14.3%
Q1 2022$5,523,000
-39.0%
65,693
-42.1%
0.01%
-36.4%
Q4 2021$9,058,000
-33.9%
113,465
-3.8%
0.01%
-26.7%
Q3 2021$13,704,000
-57.9%
117,958
-18.8%
0.02%
-70.6%
Q2 2021$32,528,000
+83.5%
145,300
+2.7%
0.05%
+96.2%
Q1 2021$17,727,000
-25.5%
141,531
-35.2%
0.03%
-55.2%
Q3 2020$23,795,000
+142.1%
218,300
+28.2%
0.06%
+114.8%
Q2 2020$9,827,000
-59.1%
170,306
-50.4%
0.03%
-63.0%
Q1 2020$24,036,000
-17.5%
343,187
+0.4%
0.07%
+2.8%
Q4 2019$29,149,000
+3.9%
341,888
-10.5%
0.07%
-12.3%
Q3 2019$28,068,000
+163.8%
382,199
+127.1%
0.08%
+170.0%
Q2 2019$10,640,000
+224.7%
168,266
+68.6%
0.03%
+200.0%
Q4 2018$3,277,000
-72.8%
99,800
-56.5%
0.01%
-61.5%
Q3 2018$12,032,000
+479.3%
229,598
+141.0%
0.03%
+420.0%
Q2 2018$2,077,0000.0%95,2770.0%0.01%0.0%
Q1 2018$2,077,000
-1.2%
95,277
-8.5%
0.01%
-37.5%
Q4 2017$2,103,000
+65.7%
104,100
+40.7%
0.01%
+33.3%
Q2 2017$1,269,000
+174.1%
74,000
+25.2%
0.01%
+100.0%
Q4 2016$463,000
+153.0%
59,100
+176.2%
0.00%
+200.0%
Q3 2016$183,000
-49.2%
21,400
-32.3%
0.00%
-50.0%
Q2 2016$360,00031,6320.00%
Other shareholders
NOVOCURE LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders